Skip to main content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

COVID-19 / SARS-CoV-2 / Coronavirus: SARS-CoV-2 / Covid-19 / Coronavirus

Library and other information resources about SARS-CoV -2 /COVID-19

The COVID-19 coverage in the Atlantic has been excellent.

Yong, Ed. 2021. “The Fundamental Question of the Pandemic Is Shifting.” The Atlantic

" “The field has moved forward since then,” Nancy Krieger, a social epidemiologist at Harvard told me. Epidemiology is rediscovering its social side, fueled by new generations of researchers who don’t come from traditional biomedical backgrounds. “When I started out in the mid-1980s, there were virtually no sessions [at academic conferences] about class, racism, and health in the U.S.” Krieger said. “Now they’re commonplace.” But these connections have yet to fully penetrate the wider zeitgeist, where they are still eclipsed by the rhetoric of personal choice: Eat better. Exercise more. Your health is in your hands.

This is the context in which today’s CDC operates, and against which its choices must be understood. The CDC represents a field that has only recently begun to rebalance itself after long being skewed toward individualism. And the CDC remains a public-health agency in one of the most individualistic countries in the world. Its mission exists in tension with its environment. Its choice to resist that tension or yield to it affects not only America’s fate, but also the soul of public health—what it is and what it stands for, whom it serves and whom it abandons."

Bastian, Hilda. 2021. “The MRNA Vaccines Are Extraordinary, but Novavax Is Even Better.” The Atlantic, June 24, 2021.

"Don’t get me wrong—the Pfizer and Moderna vaccines have been extraordinary lifesavers in this pandemic, and we may well be heading into a new golden age of vaccine development. (This week, BioNTech started injections in an early trial for an mRNA vaccine for melanoma.) But even the best experts at predicting which drugs are going to be important get things wrong quite a bit, overestimating some treatments and underestimating others. Pharmaceuticals are generally a gamble.

But here’s what we know today, based on information that we have right now:  Among several wonderful options, the more old-school vaccine from Novavax combines ease of manufacture with high efficacy and lower side effects. For the moment, it’s the best COVID-19 vaccine we have."

Trying to make sense of coronavirus COVID-19? News, data, and government sources

I like these Canadian reporters, Branswell. They consistently link to a other good of Covid-19 in eastern North America 3/5/2020 (Johns Hopkins)

Research -- Where to start

You will still probably want to start with PubMed.  But see LitCoVid version, link just below.

Note -- These are not the best links for full text access to content other than for coronavirus Covid-19. 

Datrmouth Atlas; Point of care resources; Translational resources

Dartmouth Atlas Project -- Mapping COVID-19

This "translational" website looks useful (by Indiana U./Purdue/Notre Dame):

Expert Reviews of Relevant and Emerging Literature

Expert Responses to Key Questions

Contact -- John Wiswell

John Wiswell  
Health Sciences Librarian       
Click here for an appointment.  Contact me by email if these times do not work.
Levine Hall 542F & Belk Library 225  (828)262-7853
Available for students, faculty, and staff.